A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. (Q39937037)
Jump to navigation
Jump to search
scientific article published on 20 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. |
scientific article published on 20 October 2009 |
Statements
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia (English)
David L Porter
Edward A Stadtmauer
Noelle V Frey
Elizabeth O Hexner
Alison W Loren
Selina M Luger
Sunita D Nasta
Donald E Tsai
Alexander E Perl
Margaret T Kasner
Stephen J Schuster
Steven C Goldstein
Jamil K Dierov
Cezary R Swider
Alan M Gewirtz
Martin Carroll
20 October 2009